|
Market Closed -
Other stock markets
|
After hours 19:55:20 | |||
| 485.65 USD | -0.08% |
|
485.31 | -0.07% |
| Market Cap | 123B 108B 99.4B 91.62B 173B 11,870B 177B 1,188B 467B 5,814B 463B 453B 20,013B | P/E 2026 * |
27.7x | P/E 2027 * | 24.4x |
|---|---|---|---|---|---|
| Enterprise Value | 110B 95.71B 88.32B 81.41B 153B 10,547B 157B 1,056B 415B 5,165B 411B 402B 17,782B | EV / Sales 2026 * |
8.39x | EV / Sales 2027 * | 7.29x |
| Free-Float |
99.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.08% | ||
| 1 week | +0.05% | ||
| Current month | -2.23% | ||
| 1 month | +5.81% | ||
| 3 months | +10.07% | ||
| 6 months | +10.03% | ||
| Current year | +7.12% |
| 1 week | 469.6 |  | 496.69 |
| 1 month | 453.21 | | 533.67 |
| Current year | 412.27 | | 533.67 |
| 1 year | 362.5 | | 533.67 |
| 3 years | 340.2 | | 533.67 |
| 5 years | 176.36 | | 533.67 |
| 10 years | 71.46 | | 533.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 2019-04-09 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -1,500 | 0.0006% | ||
| 7/2/26 | Sell | Executive/Senior Manager | -1,541 | 0.0006% | ||
| 7/1/26 | Sell | General Counsel | -828 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.08% | +0.05% | +4.83% | +35.66% | 123B | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.11% | +0.49% | +25.80% | +53.81% | 369.83B | |
| Weighted average by Cap. | +0.21% | +0.02% | +36.65% | +79.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.05B 11.4B 10.52B 9.7B 18.28B 1,256B 18.68B 126B 49.46B 615B 48.99B 47.92B 2,118B | 14.34B 12.54B 11.57B 10.66B 20.1B 1,381B 20.54B 138B 54.38B 677B 53.87B 52.69B 2,329B |
| Net income | 4.52B 3.95B 3.64B 3.36B 6.33B 435B 6.47B 43.55B 17.13B 213B 16.97B 16.6B 734B | 5.17B 4.52B 4.17B 3.85B 7.25B 498B 7.41B 49.86B 19.61B 244B 19.43B 19B 840B |
| Net Debt | -13.74B -12.01B -11.08B -10.22B -19.25B -1,323B -19.68B -132B -52.1B -648B -51.61B -50.48B -2,231B | -18.69B -16.33B -15.07B -13.89B -26.18B -1,799B -26.76B -180B -70.84B -881B -70.17B -68.63B -3,034B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$485.65 | -0.08% | 1,568,122 |
| 26-07-16 | US$486.03 | +1.88% | 1,370,959 |
| 26-07-15 | US$477.08 | +0.16% | 1,192,070 |
| 26-07-14 | US$476.31 | -0.82% | 1,093,659 |
| 26-07-13 | US$480.25 | -1.06% | 1,153,856 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition